Jabbari Alireza, Hadian Marziye, Mazaheri Elaheh, Jelodar Zahra Khakdel
Associate Professor, Health Services Management, Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Student Research Committee, Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
J Educ Health Promot. 2023 Jan 31;12:32. doi: 10.4103/jehp.jehp_928_21. eCollection 2023.
With more than 12 million new cases of cancers and nearly 7.6 million deaths worldwide in 2020, cancer is currently the third leading cause of mortality in the world. The costs spent on treating patients with cancer account for a significant amount of healthcare costs. Healthcare expenditures for cancer treatment have also increased significantly and are projected to skyrocket further over the next decade. This study was conducted to determine medical and non-medical direct costs for the prevention of cancer in patients hospitalized in 10 selected educational hospitals in Iran.
The study employed a cross-sectional design and was conducted in 10 selected educational hospitals in Tabriz, Tehran, Isfahan, Mashhad, and Shiraz in 2020. Using a researcher-made questionnaire, we assessed direct medical costs and direct non-medical costs of cancer in patients over 20 years old with kinds of breast, prostate, leukemia, lymphatic, stomach, liver, lung, bladder, uterine, and intestine cancers who undertook oncology treatments ( = 2410). Data were analyzed using descriptive statistics including mean and standard deviation and analytic statistics such as Kolmogorov-Smirnov, analysis of variance, and t-test, using SPSS 18 and ≤0.05.
The mean direct non-medical cost paid out of pocket per month was $99.6 ± $10.81 USD, and the mean direct medical cost per month was $1029.4 ± $68.5 USD. The total cost paid by the patients was $889.4 ± 69.81 USD per month.
Given the increasing number of patients with cancer, it is necessary to increase the number of special centers for the prevention and treatment of cancers. Dissemination of information about the costs of illnesses and their complications enables decision-makers to make a proper comparison between different uses of resources. Moreover, to support the patients, the health system must implement plans to decrease out-of-pocket payments by patients.
2020年全球新增癌症病例超过1200万，死亡近760万，癌症目前是全球第三大死因。用于治疗癌症患者的费用占医疗保健费用的很大一部分。癌症治疗的医疗保健支出也大幅增加，预计在未来十年还将进一步飙升。本研究旨在确定伊朗10家选定的教学医院中住院患者预防癌症的医疗和非医疗直接成本。
本研究采用横断面设计，于2020年在大不里士、德黑兰、伊斯法罕、马什哈德和设拉子的10家选定的教学医院进行。我们使用自制问卷，评估了20岁以上接受肿瘤治疗的乳腺癌、前列腺癌、白血病、淋巴癌、胃癌、肝癌、肺癌、膀胱癌、子宫癌和肠癌患者的癌症直接医疗成本和直接非医疗成本（=2410）。使用SPSS 18软件，采用包括均值和标准差在内的描述性统计以及诸如柯尔莫哥洛夫-斯米尔诺夫检验、方差分析和t检验等分析性统计方法对数据进行分析，P≤0.05。
每月自付的平均直接非医疗成本为99.6±10.81美元，每月平均直接医疗成本为1029.4±68.5美元。患者每月支付的总成本为889.4±69.81美元。
鉴于癌症患者数量不断增加，有必要增加癌症预防和治疗的专科中心数量。传播疾病及其并发症成本的信息，使决策者能够对资源的不同用途进行适当比较。此外，为了支持患者，卫生系统必须实施计划以减少患者的自付费用。
